MNPR Monopar Therapeutics Inc. logo

MNPR Monopar Therapeutics Inc.

Healthcare
$62.62-0.79%ClosedMarket Cap: $419.5M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

4

Dispositions

4

Buy/Sell Ratio

1.00

Net Shares

+47,185

Shares Acquired

60,974

Shares Disposed

13,789

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Robinson Chandlerdirector, officer: Chief Executive OfficerSell6,732$0.00106,276
Thu Apr 02Robinson Chandlerdirector, officer: Chief Executive OfficerSell1,972$54.7990,478
Thu Apr 02Cittadine Andrewofficer: Chief Operating OfficerSell3,514$0.0054,240
Thu Apr 02Cittadine Andrewofficer: Chief Operating OfficerSell1,571$54.7952,669
Wed Mar 04Rodriguez Susanofficer: CCSOSell48,728$53.4748,728
Wed Mar 04Rodriguez SusanofficerSell0$0.000
Fri Jan 30Robinson Chandlerdirector, officer: Chief Executive OfficerSell62,815$0.0062,815
Mon Jan 05Robinson Chandlerdirector, officer: Chief Executive OfficerSell8,724$0.00113,008
Mon Jan 05Robinson Chandlerdirector, officer: Chief Executive OfficerSell2,558$65.3085,718
Mon Jan 05RIOUX PATRICEother: Acting Chief Medical OfficerSell2,000$65.302,000
Mon Jan 05Cittadine Andrewofficer: Chief Operating OfficerSell4,326$0.0052,615
Mon Jan 05Cittadine Andrewofficer: Chief Operating OfficerSell1,889$65.3050,726